相关实验视频
Updated: Jan 18, 2026

07:33
Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
23.9K
在急性淋巴细胞白血病的成年人管理前期免疫疗法方法
Moazzam Shahzad1, Muhammad Kashif Amin2, Talha Badar3
1Division of Hematology and Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.
Cancers
|September 13, 2025
概括
新的免疫疗法方案正在改变B细胞前体急性淋巴细胞白血病 (BCP-ALL) 的成年人治疗方法,提供高疗效与降低毒性. 这些无化疗或轻化疗方法旨在实现持久的缓解和改善结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 成人B细胞前体急性淋巴细胞白血病 (BCP-ALL) 的治疗正在发展.
- 传统的密集化疗带来了毒性挑战,尤其是对老年人来说.
- 基于免疫治疗的新型策略提供了具有潜在副作用降低的替代方案.
研究的目的:
- 审查成人BCP-ALL无化疗和化疗光疗方案的新兴景观.
- 突出免疫疗法组合在费城染色体阳性 (Ph+) 和费城染色体阴性 (Ph-) 患者的疗效和安全性. BCP-ALL.
- 讨论这些新策略的潜力,以重新定义护理标准.
主要方法:
- 目前临床研究和针对成人BCP-ALL免疫疗法治疗的试验数据的综述.
- 对结果的分析,包括响应率,分子缓解和存活率.
- 对毒性概况的评估和与传统化疗的比较.
主要成果:
- 对于Ph+ BCP-ALL,ABL氨酸激酶抑制剂 (TKIs) 与布利纳马布结合,显示出高响应率 (90-100%) 和在没有强化化疗或alo-HCT的情况下的生存率 (>80%).
- 对于Ph-BCP-ALL,blinatumomab加上 inotuzumab和ozogamicin实现了高度的完全缓解和MRD负面率,具有可控的毒性.
- 化学抗原受体 (CAR) T细胞疗法对复发性/耐药性疾病有效,目前正在对其前线使用进行研究.
结论:
- 基于免疫治疗的无化疗和轻化疗方案正在彻底改变成人BCP-ALL治疗.
- 这些策略提供了一种有希望的疗效和降低毒性的平衡,可能避免在特定患者中需要密集化疗和alo-HCT.
- 不断变化的治疗环境旨在改善长期结果,并减少与治疗相关的发病率.
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Bone Marrow Sampling and Transplants
910
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
910

